Nifty Pharma Today: Index Falls 0.90% as 16 Stocks Decline

Updated: 14 Aug 2026 • 4:19 pm

Posted by:

Nifty Pharma Today: Index Falls 0.90% as 16 Stocks Decline

Quick sector takeaways

Nifty Pharma ended 0.90% lower, down 241.25 points at 26,445.55 against the previous close of 26,686.80.
The index moved between 26,714.25 and 26,393.95 during the session, finishing closer to the day’s low than its high.
Market breadth was weak: 16 of 20 displayed stocks declined, while four advanced and none were unchanged.
Natco Pharma, JB Chemicals & Pharmaceuticals, Laurus Labs and Ipca Laboratories were among the sharpest losers, while Ajanta Pharma led the gainers. The next-session watch is whether breadth improves from the 4:16 advance-decline split.

Nifty Pharma today reflected broad end-of-session pressure across the sector. The index closed at 26,445.55 on 14 August 2026, with the update recorded at 4:15:00 PM IST. The 0.90% decline made pharma the top losing sector index among the configured sector indices tracked in this session.

Nifty Pharma today: closing-bell wrap

Nifty Pharma began at 26,659.65, below its previous close of 26,686.80. It briefly reached 26,714.25, marginally above the prior close, before moving lower through the session. The index eventually touched 26,393.95 and settled at 26,445.55, a decline of 241.25 points.

The close was 51.60 points above the intraday low and 268.70 points below the day’s high. This placed the finish in the lower part of the session’s 320.30-point range. In simple terms, the sector had an early upward stretch but ended the day under pressure.

For readers tracking Univest Market View, the pharma index’s closing position and the breadth within its displayed stocks provide the clearest session-level reference points. The index move is an aggregate reading, while the individual stock moves show how widely that pressure was distributed.

Price snapshot

Measure	Level	Session reading
Previous close	26,686.80	Reference level for the day
Open	26,659.65	Opened below the previous close
Day high	26,714.25	Highest level of the session
Day low	26,393.95	Lowest level of the session
Close/LTP	26,445.55	Down 241.25 points, or 0.90%

The day’s numbers show that Nifty Pharma finished below both its opening level and previous close. The intraday range also illustrates that the final reading did not recover to the session high. These are observations from the price path rather than a forecast of the next move.

Sector ranking

Nifty Pharma was the top losing sector index in the configured sector-index set on 14 August. Its 0.90% fall was steeper than the declines recorded by Nifty Mid Select and Nifty Metal, both down 0.71%, Nifty Auto, down 0.63%, Nifty FMCG, down 0.46%, Nifty Financial Services, down 0.43%, Nifty IT, down 0.31%, and Nifty Bank, down 0.25%.

This ranking is based on percentage movement for the session. The 241.25-point decline in Nifty Pharma should therefore be viewed alongside its 0.90% fall, which is the comparable measure across indices at different levels.

Constituent breadth

The displayed Nifty Pharma universe showed a distinctly negative breadth profile. Sixteen stocks declined and four rose, producing an advance-decline ratio of 0.25. No displayed stock was unchanged. That means decliners outnumbered advancers by four to one, aligning with the index’s negative close.

Broad participation matters because an index decline driven across many stocks conveys a different session picture from one led by only a small number of names. Here, the 16 decliners included both large and mid-sized pharma names, while the four gainers offered only selective counter-moves.

Heavyweights versus broader participation

The supplied heavyweight set was also largely lower. Sun Pharmaceutical Industries slipped 0.10% to 1,930.00, Divi’s Laboratories fell 0.27% to 8,477.00, Torrent Pharmaceuticals lost 1.66% to 4,833.00, Cipla declined 0.60% to 1,450.00, and Dr. Reddy’s Laboratories eased 0.50% to 1,200.00.

The supplied most-active stock set contains the same five names. Their broadly lower closing moves were consistent with the sector’s overall decline, while Torrent Pharmaceuticals stood out within this group with a 1.66% fall. Sun Pharmaceutical Industries, by contrast, was comparatively steadier, down only 0.10%.

Key Nifty Pharma stocks

Stock	Move	Why it matters
Natco Pharma	903.15, down 5.10%	Sharpest percentage decline among the listed sector losers.
JB Chemicals & Pharmaceuticals	2,408.90, down 3.87%	One of the deepest declines in a weak breadth session.
Laurus Labs	1,787.30, down 3.48%	Finished lower after trading between 1,853.20 and 1,777.70.
Ajanta Pharma	3,672.80, up 1.61%	Strongest positive mover among the displayed stocks.
Alkem Laboratories	5,368.00, down 1.50%	Its lower close added to the broad negative participation.

Biggest positive movers

Ajanta Pharma led the gainers with a 1.61% rise to 3,672.80, after trading between 3,603.10 and 3,700.60. Mankind Pharma advanced 0.87% to 2,425.20. Granules India added 0.10% to 858.40, while Gland Pharma rose 0.09% to 2,970.20.

These four advances show that the sector was not uniformly lower. However, their number and scale were insufficient to alter the wider negative breadth reading at the close.

Biggest negative movers

Natco Pharma fell 5.10% to 903.15, after a day range of 886.35 to 964.85. JB Chemicals & Pharmaceuticals declined 3.87% to 2,408.90, Laurus Labs fell 3.48% to 1,787.30, and Ipca Laboratories dropped 3.46% to 1,734.20. Zydus Lifesciences lost 2.75% to 1,135.20.

Among these names, Zydus Lifesciences closed at its intraday low of 1,135.20, while Natco Pharma ended above its low of 886.35. These closing positions describe the day’s trading range and do not indicate a reason for the moves.

Stocks to watch next session

Natco Pharma, after a 5.10% decline and a 78.50-point intraday range.
JB Chemicals & Pharmaceuticals, which fell 3.87% to 2,408.90.
Ajanta Pharma, the sector’s leading gainer at 1.61%.
Torrent Pharmaceuticals, down 1.66% and closing at its day low of 4,833.00.
Zydus Lifesciences, which ended at its session low.
Sun Pharmaceutical Industries, which was comparatively stable at a 0.10% decline.

The constructive case

The constructive evidence lies in the presence of four advancers despite the sector-wide decline. Ajanta Pharma and Mankind Pharma posted notable gains, and Granules India and Gland Pharma also finished positive. The index additionally closed 51.60 points above its intraday low, showing some distance from the weakest level of the day.

Investors can also note that certain heavyweight names recorded relatively contained declines. Sun Pharmaceutical Industries was down 0.10%, Divi’s Laboratories was down 0.27%, and Dr. Reddy’s Laboratories was down 0.50%. This relative stability within selected larger names contrasted with sharper falls elsewhere in the sector.

The cautious case

The cautious case is anchored in the 0.90% index decline and the 16:4 decliner-to-advancer split. Nifty Pharma closed below its open and previous close, and its finish remained much nearer the day’s low than the day’s high.

Several stocks fell by more than 2%, including Natco Pharma, JB Chemicals & Pharmaceuticals, Laurus Labs, Ipca Laboratories, Zydus Lifesciences, Aurobindo Pharma and Abbott India. The breadth and scale of these declines are the key cautionary observations from the session.

Univest Insights

Nifty Pharma today closed as the weakest configured sector index, combining a 0.90% fall with broad negative participation. The session started below the previous close, briefly moved above it, and then settled lower at 26,445.55.

The index range of 26,393.95 to 26,714.25 provides a concise map of the day’s movement. Its close in the lower part of that range keeps attention on whether the sector can show a broader recovery in the next session.

The divergence between Ajanta Pharma’s 1.61% rise and Natco Pharma’s 5.10% decline underlines the importance of monitoring stock-level moves alongside the index. The relative steadiness in Sun Pharmaceutical Industries, Divi’s Laboratories and Dr. Reddy’s Laboratories also remains relevant within the wider sector reading.

For traders and investors, the key signal to watch is…

Published on 14 August 2026 at 4:18 PM IST

Frequently asked questions

What was Nifty Pharma today?

Nifty Pharma closed at 26,445.55 on 14 August 2026, down 241.25 points or 0.90% from the previous close of 26,686.80.

Why was Nifty Pharma the top losing sector index?

Its 0.90% decline was the largest percentage fall among the configured sector indices in the session.

What were Nifty Pharma’s day high and day low?

The index recorded a day high of 26,714.25 and a day low of 26,393.95.

How was the breadth within Nifty Pharma?

Among 20 displayed stocks, four advanced, 16 declined and none were unchanged.

Which stocks were the top gainers in Nifty Pharma?

Ajanta Pharma gained 1.61%, followed by Mankind Pharma at 0.87%, Granules India at 0.10% and Gland Pharma at 0.09%.

Which stocks were the biggest losers in Nifty Pharma?

Natco Pharma fell 5.10%, JB Chemicals & Pharmaceuticals declined 3.87%, Laurus Labs lost 3.48%, and Ipca Laboratories dropped 3.46%.

Disclaimer

Investments in securities markets are subject to market risks. Read all related documents carefully before investing. This sector-index update is for informational and educational purposes only and is not personalized investment advice or a recommendation to buy, sell, or hold any security.